Kopfbereich

additional navigation

Logo


Corporate Profile Folder

Download Corporate Profile Folder (.pdf, 3.6 MB)


Hauptinhalt

A Pioneer in Rare Diseases

AOP Orphan was one of the first companies to enter the sector of rare diseases in Europe and to this day, continues to be a trailblazer in the field of Orphan Diseases. As a specialist in Orphan Diseases, AOP Orphan researches, develops, produces, and distributes innovative solutions in the following therapeutic areas: hematology and oncology, cardiology and pulmonology, neurology and psychiatry, and metabolic diseases. Today AOP Orphan is active at an international scale with an export ratio of about 70% and has become a leading company in its home branch.

News

AOP Orphan Pharmaceuticals AG, the Austrian specialist for rare diseases, will implement ‘Mobile IntelligenceTM (MI)’ - the smart CRM Tool from leading Life-Sciences...

AOP Orphan supports the Christian Doppler Laboratory for Iron Metabolism and Anemia Research at the Medical University of Innsbruck, Austria, opening on January 31st,...


AOP Orphan Contact

AOP Orphan Germany

AOP Orphan worldwide

Products & Area of treatment